Login

Inställningar

Split view

Short keys for navigating in split view

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Dark Mode

Set dark mode to MFN.se

Sound

Plays a notification sound when new press release is published in the current feed

Torsdag 23 Januari | 22:01:27 Europe / Stockholm

Svenska | English

2025-01-23 13:00:00

Estimates compiled by Modular Finance on behalf of XVIVO Perfusion.

Number of contributors: 6 (all of which have been updated or confirmed before the report)

KPI (MSEK, unless otherwise specified)	Q4 2024E
Net sales	213
Organic growth in local currency (%)	35.6
Gross profit	162
EBITDA	47
EBIT	27
Net profit	17
Earnings per share (SEK)	0.58

XVIVO Perfusion’s Q4 report will be released on Tuesday, January 28, 2025 at 07.30 am CET.